GovChime
Notice ID: 5b9401238c234add96f822b26b7b2b57Award NoticeAwarded

6505--UPTRAVI Medication

Awarded on January 30, 2023. Full description on SAM.gov.

Awarded tounder 36C24623P0524 (source: SAM.gov award notice)• $160.4K

Overview

Posted
January 30, 2023
Notice type
Award Notice

Notice details

Last updated
Sep 9, 2025
Award date
Jan 30, 2023
Award amount (SAM.gov award notice)
$160.4K

Identifiers

Solicitation number
36C24623P0524
Notice ID
5b9401238c234add96f822b26b7b2b57
Award number (PIID)
36C24623P0524

Description

NOTICE OF INTENT TO AWARD SOLE SOURCE Project Title: Uptravi 1600mcg Announcement No.: 36C24623P0524 The Government hereby submits a notice of intent to award a sole source Firm-Fixed-Price, open market, purchase order for Uptravi medication. Selexipag lowers blood pressure in your lungs by dilating (widening) blood vessels that supply blood to the lungs. Selexipag is used to treat pulmonary arterial hypertension (PAH). Selexipag helps keep your condition from getting worse and helps lower your risk of needing to be hospitalized for PAH. The total estimated value is $175,014.36. Market research has determined there are no generic forms of this drug and Actelion Pharmaceuticals a large business are the sole manufacturers of this drug. Actelion Pharmaceuticals utilizes Accredo Health Group a large business as their authorized distributors. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of the Fayetteville VAMC. The determination not to compete this proposed contract action is solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is not a request for quote or proposals. Questions or comments to this Notice of Intent should be directed to Contracting Specialist, Isaac Hernandez at Isaac.Hernandez@va.gov (no phone calls/voice mail messages regarding questions will be accepted and will not received a response). Please indicate in the subject of your email: Notice of Intent Question Submission 36C24623P0524.

Full description on SAM.gov

Award Overview

Award Number

36C24623P0524

Award Amount (SAM.gov award notice)

$160.4K

Award Date

Jan 30, 2023

Awardee

Awardee UEI

LERPSGUE3528

Original Solicitation

Notice ID: 5b9401238c234add96f822b26b7b2b57

Posted Date: Jan 30, 2023

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 36C26025P0979
    ACCREDO HEALTH GROUP, INC
    Department of Veterans AffairsNAICS 325412
    $13.4KSigned Apr 3, 2026
  • 36C26025P0576
    ACCREDO HEALTH GROUP, INC
    Department of Veterans AffairsNAICS 325412
    $134.2KSigned Mar 5, 2026
  • 36C25926P0120
    ACCREDO HEALTH GROUP, INC
    Department of Veterans AffairsNAICS 325412
    $11.2KSigned Jan 9, 2026
  • 36C26225P0903
    ACCREDO HEALTH GROUP, INC
    Department of Veterans AffairsNAICS 325412
    $78.6KSigned Dec 23, 2025
  • 36C24925P0570
    ACCREDO HEALTH GROUP, INC
    Department of Veterans AffairsNAICS 325412
    $8.5KSigned Sep 25, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36C24623P0524
  1. Awarded

This opportunity has been awarded.

  1. Special NoticeJan 23, 2023

    6505--UPTRAVI Medication

    Notice bcc9b7d1e92e4adb89f413377414da39 on SAM.gov

  2. AwardedCurrentJan 30, 2023

    6505--UPTRAVI Medication

    Notice 5b9401238c234add96f822b26b7b2b57 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36C24623P0524

Archive Date

Feb 13, 2023

Office Address

HAMPTON, VA, 23667